Latest Capital Raising News

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.

Larvotto Resources has raised $10 million through a Share Purchase Plan, bolstering its financial position as it advances the Hillgrove Project toward production slated for Q2 2026.

DUG Technology reported a record US$52 million order book and strong second-half momentum in FY25, driven by innovative seismic imaging technology and global office expansions despite a slight revenue dip.

DUG Technology reports a landmark US$52 million services order book for FY25 despite a net loss, driven by new imaging tech and mobile data centre launches.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

BCI Minerals reported a $47 million net loss for FY25, driven by heavy spending on the Mardie Salt and Potash Project, while gains from the Iron Valley asset sale partially offset the hit.

Vysarn Limited delivered a robust FY2025 performance, driven by significant acquisitions and expanding operations across Australia’s water infrastructure sector. The company’s strategic moves position it well for sustained growth amid evolving market demands.

SRJ Technologies has successfully raised A$2.53 million through its entitlement offer, positioning the company to advance a significant joint venture and acquisition in the Middle East.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Qualitas Limited has reported a robust FY25 with net profit after tax rising 28% to $33.4 million and funds under management growing to $9.5 billion. The company also declared a fully franked final dividend of 7.5 cents per share.

EPX Limited has successfully raised $2 million through a private placement, positioning itself to expand sales, explore acquisitions, and enhance its energy efficiency technology platform.

Cryosite Limited reported a 12% increase in revenue for FY25, driven by a 58% surge in its ultra-frozen and cryogenic segment, while deferring dividends to fund expansion plans.